PIK3CA and neoplasm: To further characterize the differential effects of zotatifin on survival of tumors, the impact of zotatifin on key signaling proteins within the PI3K and/or RAS pathways were evaluated across a panel of zotatifin-sensitive and non-sensitive RTK-driven tumor cell lines.